Cargando...
Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study
BACKGROUND: To compare the adverse events after initiation of nevirapine-based ART among HIV-infected patients who did not receive fluconazole (group A), received fluconazole 400 mg/week (group B), and received fluconazole 200 mg/day (group C). METHODS: A retrospective cohort study was conducted amo...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1199598/ https://ncbi.nlm.nih.gov/pubmed/16120209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-5-67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|